The Prognostic Impact of Bleeding and Ischemic Events on Mortality in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Results From a Multicenter Registry

被引：0
|
作者：
Otsuki, Hisao [1 ]
Yamaguchi, Junichi [1 ]
Inagaki, Yusuke [1 ]
Ebihara, Suguru [1 ]
Tanaka, Kazuki [1 ]
Nakao, Masashi [1 ]
Hagiwara, Nobuhisa [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 74卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2019.08.643
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-540
引用
收藏
页码：B533 / B533
页数：1
相关论文
共 50 条
  • [1] MORTALITY FOLLOWING BLEEDING IN ATRIAL FIBRILLATION PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Shanmugasundaram, Madhan
    Hashemzadeh, Mehrtash
    Movahed, Mohammad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1023 - 1023
  • [2] Validation of a Prognostic Risk Score for Major Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention: From the SHINANO Registry
    Senda, Keisuke
    Miura, Takashi
    Mochidome, Tomoaki
    Sakai, Takahiro
    Minamisawa, Masatoshi
    Kato, Tamon
    Saigusa, Tatsuya
    Ebisawa, Soichiro
    Motoki, Hirohiko
    Kuwahara, Koichiro
    CIRCULATION, 2017, 136
  • [3] Influence of Renal Dysfunction for Ischemic Stroke and Major Bleeding in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Yamamoto, Ko
    Shiomi, Hiroki
    Takeji, Yasuaki
    Natsuaki, Masahiro
    Watanabe, Hirotoshi
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B600 - B600
  • [4] Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention
    Yamamoto, Ko
    Shiomi, Hiroki
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Takeji, Yasuaki
    Watanabe, Hirotoshi
    Yoshikawa, Yusuke
    Matsumura-Nakano, Yukiko
    Shizuta, Satoshi
    Tanabe, Kengo
    Ando, Kenji
    Kadota, Kazushige
    Morino, Yoshihiro
    Kozuma, Ken
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (03): : 399 - 408
  • [5] Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
    Puurunen, Marja
    Kiviniemi, Tuomas
    Nammas, Wail
    Schlitt, Axel
    Rubboli, Andrea
    Nyman, Kai
    Karjalainen, Pasi
    Kirchhof, Paulus
    Lip, Gregory Y. H.
    Airaksinen, Juhani K. E.
    BMJ OPEN, 2014, 4 (05):
  • [6] IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY
    Puurunen, Marja Kaarina
    Kiviniemi, Tuomas
    Nammas, Wail
    Schlitt, Axel
    Rubboli, Andrea
    Nyman, Kai
    Karjalainen, Pasi
    Kirchhof, Paulus
    Lip, Gregory
    Airaksinen, Juhani
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1857 - A1857
  • [7] Patients with atrial fibrillation undergoing percutaneous coronary intervention
    Dzeshka, Mikhail S.
    Brown, Richard A.
    Lip, Gregory Y. H.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (1-2): : 73 - +
  • [8] Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Sulzgruber, Patrick
    Hofer, Felix
    Kazem, Niema
    Hammer, Andreas
    Niessner, Alexander
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 875 - 876
  • [9] Octogenarians with atrial fibrillation undergoing percutaneous coronary intervention - the AFCAS registry
    Lahtela, H.
    Bah, A.
    Kiviniemi, T.
    Schlitt, A.
    Rubboli, A.
    Karjalainen, P. P.
    Hartikainen, J. E. K.
    Airaksinen, K. E. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 677 - 678
  • [10] Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Patrick Sulzgruber
    Felix Hofer
    Niema Kazem
    Andreas Hammer
    Alexander Niessner
    Cardiovascular Drugs and Therapy, 2021, 35 : 875 - 876
12345